Clinical Metabolomics Paves the Way Towards Future Healthcare Strategies

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2012 Feb 22

PMID 22348240

Citations 34

Authors

Sebastiano Collino

Francois-Pierre J Martin

Serge Rezzi

Affiliations

Soon will be listed here.

Abstract

Metabolomics is recognized as a powerful top-down system biological approach to understand genetic-environment-health paradigms paving new avenues to identify clinically relevant biomarkers. It is nowadays commonly used in clinical applications shedding new light on physiological regulatory processes of complex mammalian systems with regard to disease aetiology, diagnostic stratification and, potentially, mechanism of action of therapeutic solutions. A key feature of metabolomics lies in its ability to underpin the complex metabolic interactions of the host with its commensal microbial partners providing a new way to define individual and population phenotypes. This review aims at describing recent applications of metabolomics in clinical fields with insight into diseases, diagnostics/monitoring and improvement of homeostatic metabolic regulation.

Citing Articles

Distinct and Overlapping Metabolites Associated with Visual Impairment and Cognitive Impairment.

Hu W, Chu T, Liao H, Wang W, Ha J, Kiburg K J Alzheimers Dis Rep. 2024; 8(1):1093-1104.

PMID: 39434817 PMC: 11491940. DOI: 10.3233/ADR-230154.

Chicoric Acid Effectively Mitigated Dextran Sulfate Sodium (DSS)-Induced Colitis in BALB/c Mice by Modulating the Gut Microbiota and Fecal Metabolites.

Yang J, Lin J, Gu T, Sun Q, Xu W, Peng Y Int J Mol Sci. 2024; 25(2).

PMID: 38255916 PMC: 10815209. DOI: 10.3390/ijms25020841.

Optimising a urinary extraction method for non-targeted GC-MS metabolomics.

Olivier C, Allen B, Luies L Sci Rep. 2023; 13(1):17591.

PMID: 37845360 PMC: 10579216. DOI: 10.1038/s41598-023-44690-7.

Comprehensive brain tissue metabolomics and biological network technology to decipher the mechanism of hydrogen-rich water on Radiation-induced cognitive impairment in rats.

Liu X, Liu M, Liu H, Yuan H, Wang Y, Chen X BMC Mol Cell Biol. 2023; 24(1):30.

PMID: 37752412 PMC: 10523633. DOI: 10.1186/s12860-023-00491-4.

Correlations for untargeted GC × GC-HRTOF-MS metabolomics of colorectal cancer.

Di Giovanni N, Meuwis M, Louis E, Focant J Metabolomics. 2023; 19(10):85.

PMID: 37740774 DOI: 10.1007/s11306-023-02047-1.

References

James O, Day C . Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998; 29(3):495-501. DOI: 10.1016/s0168-8278(98)80073-1. View

Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J . Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009; 4(7):e6386. PMC: 2713417. DOI: 10.1371/journal.pone.0006386. View

Oresic M, Tang J, Seppanen-Laakso T, Mattila I, Saarni S, Saarni S . Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med. 2011; 3(3):19. PMC: 3092104. DOI: 10.1186/gm233. View

Sawyers C . The cancer biomarker problem. Nature. 2008; 452(7187):548-52. DOI: 10.1038/nature06913. View

Rezzi S, Martin F, Shanmuganayagam D, Colman R, Nicholson J, Weindruch R . Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates. Exp Gerontol. 2009; 44(5):356-62. PMC: 2822382. DOI: 10.1016/j.exger.2009.02.008. View

Tiniakos D, Vos M, Brunt E . Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010; 5:145-71. DOI: 10.1146/annurev-pathol-121808-102132. View

Fiehn O, Garvey W, Newman J, Lok K, Hoppel C, Adams S . Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010; 5(12):e15234. PMC: 3000813. DOI: 10.1371/journal.pone.0015234. View

Johnson N, Walton D, Sachinwalla T, Thompson C, Smith K, Ruell P . Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology. 2008; 47(5):1513-23. DOI: 10.1002/hep.22220. View

Martin F, Montoliu I, Kochhar S, Rezzi S . Chemometric strategy for modeling metabolic biological space along the gastrointestinal tract and assessing microbial influences. Anal Chem. 2010; 82(23):9803-11. DOI: 10.1021/ac102015n. View

10.

Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R . A role for inflammation in irritable bowel syndrome?. Gut. 2002; 51 Suppl 1:i41-4. PMC: 1867730. DOI: 10.1136/gut.51.suppl_1.i41. View

11.

Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn E . Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Am J Gastroenterol. 2002; 97(12):3071-7. DOI: 10.1111/j.1572-0241.2002.07028.x. View

12.

Wikoff W, Anfora A, Liu J, Schultz P, Lesley S, Peters E . Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009; 106(10):3698-703. PMC: 2656143. DOI: 10.1073/pnas.0812874106. View

13.

Huffman K, Shah S, Stevens R, Bain J, Muehlbauer M, Slentz C . Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009; 32(9):1678-83. PMC: 2732163. DOI: 10.2337/dc08-2075. View

14.

Huffman K, Slentz C, Bateman L, Thompson D, Muehlbauer M, Bain J . Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity. Diabetes Care. 2010; 34(1):174-6. PMC: 3005483. DOI: 10.2337/dc10-0709. View

15.

Rezzi S, Ramadan Z, Martin F, Fay L, Van Bladeren P, Lindon J . Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res. 2007; 6(11):4469-77. DOI: 10.1021/pr070431h. View

16.

Balasubramanian K, Kumar S, Singh R, Sharma U, Ahuja V, Makharia G . Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging. 2008; 27(1):79-86. DOI: 10.1016/j.mri.2008.05.014. View

17.

Fabbrini E, Sullivan S, Klein S . Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2009; 51(2):679-89. PMC: 3575093. DOI: 10.1002/hep.23280. View

18.

Williams H, Cox I, Walker D, North B, Patel V, Marshall S . Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009; 104(6):1435-44. DOI: 10.1038/ajg.2009.175. View

19.

Nicholson J, Lindon J . Systems biology: Metabonomics. Nature. 2008; 455(7216):1054-6. DOI: 10.1038/4551054a. View

20.

Yap I, Angley M, Veselkov K, Holmes E, Lindon J, Nicholson J . Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010; 9(6):2996-3004. DOI: 10.1021/pr901188e. View